These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19582316)

  • 1. Clinical characteristics and premorbid variables in childhood-onset schizophrenia: a descriptive study of twelve cases from a schizophrenia founder population.
    Maydell RJ; van der Walt C; Roos JL; Scribante L; Ladikos A
    Afr J Psychiatry (Johannesbg); 2009 May; 12(2):144-8. PubMed ID: 19582316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The meaning of childhood attention-deficit hyperactivity symptoms in patients with a first-episode of schizophrenia-spectrum psychosis.
    Peralta V; de Jalón EG; Campos MS; Zandio M; Sanchez-Torres A; Cuesta MJ
    Schizophr Res; 2011 Mar; 126(1-3):28-35. PubMed ID: 20926260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical psychopathological research on late-onset schizophrenia--mainly patients with schizophrenia from a hospital psychiatric ward].
    Yasuda M; Kato S
    Seishin Shinkeigaku Zasshi; 2009; 111(3):250-71. PubMed ID: 19425390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison study of early non-psychotic deviant behavior in Afrikaner and US patients with schizophrenia or schizoaffective disorder.
    Sobin C; Roos JL; Pretorius H; Lundy LS; Karayiorgou M
    Psychiatry Res; 2003 Feb; 117(2):113-25. PubMed ID: 12606014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
    Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12 year chart review of childhood and adolescent onset psychosis at a Nigerian tertiary mental health facility.
    Okewole AO; Ogunwale A; Mosanya TJ; Ojo BM
    J Child Adolesc Ment Health; 2016 Oct; 28(3):189-197. PubMed ID: 27998263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenia in children and adolescents: relevance and differentiation from adult schizophrenia].
    Androutsos Ch
    Psychiatriki; 2012 Jun; 23 Suppl 1():82-93. PubMed ID: 22796977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Gender-Related Differences in Childhood-Onset Schizophrenia.
    Ordóñez AE; Loeb FF; Zhou X; Shora L; Berman RA; Broadnax DD; Gochman P; Liu S; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 2016 Sep; 55(9):792-9. PubMed ID: 27566120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining which factors influence age of onset in males and females with schizophrenia.
    Neill E; Tan EJ; Toh WL; Selvendra A; Morgan VA; Rossell SL; Castle DJ
    Schizophr Res; 2020 Sep; 223():265-270. PubMed ID: 32883558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series.
    Tossell JW; Greenstein DK; Davidson AL; Job SB; Gochman P; Lenane M; Nugent Iii TF; Gogtay N; Sporn AL; Rapoport JL
    J Child Adolesc Psychopharmacol; 2004; 14(3):448-54. PubMed ID: 15650502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurodevelopmental Disorders, Psychiatric Comorbidities and Associated Pathologies in Patients with Childhood-Onset Schizophrenia and Premorbid Autistic Symptoms.].
    Fernandez A; Pasquet-Levy M; Laure G; Thümmler S; Askenazy F
    Can J Psychiatry; 2021 Dec; 66(12):1042-1050. PubMed ID: 33563032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.
    Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Pfanner C
    Bipolar Disord; 2006 Aug; 8(4):373-81. PubMed ID: 16879138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different psychological effects of cannabis use in adolescents at genetic high risk for schizophrenia and with attention deficit/hyperactivity disorder (ADHD).
    Hollis C; Groom MJ; Das D; Calton T; Bates AT; Andrews HK; Jackson GM; Liddle PF
    Schizophr Res; 2008 Oct; 105(1-3):216-23. PubMed ID: 18768298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and functional implications of a history of childhood ADHD in first-episode psychosis.
    Rho A; Traicu A; Lepage M; Iyer SN; Malla A; Joober R
    Schizophr Res; 2015 Jul; 165(2-3):128-33. PubMed ID: 25921441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Multidimensionally impaired disorder": is it a variant of very early-onset schizophrenia?
    Kumra S; Jacobsen LK; Lenane M; Zahn TP; Wiggs E; Alaghband-Rad J; Castellanos FX; Frazier JA; McKenna K; Gordon CT; Smith A; Hamburger S; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):91-9. PubMed ID: 9444905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study.
    Asarnow RF; Nuechterlein KH; Fogelson D; Subotnik KL; Payne DA; Russell AT; Asamen J; Kuppinger H; Kendler KS
    Arch Gen Psychiatry; 2001 Jun; 58(6):581-8. PubMed ID: 11386988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.